Resultados de la búsqueda 81-90 of 12990 for Enzyme

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Abemaciclib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Olaparib is an inhibitor of PARP, an enzyme that helps ...

2. Aumento de enzimas hepáticas Causas - Mayo Clinic

   17, 2020. Jan. 06, 2022. Original article: https://www.mayoclinic.org/es-es/symptoms/elevated-liver-enzymes/basics/causes/sym-20050830 . Mayo Clinic Footer ...

3. Aumento de enzimas hepáticas Cuándo consultar al doctor - Mayo Clinic

   17, 2020. Jan. 06, 2022. Original article: https://www.mayoclinic.org/es/symptoms/elevated-liver-enzymes/basics/when-to-see-doctor/sym-20050830 . Mayo Clinic ...

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Vismodegib and FAK inhibitor GSK2256098 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Inotuzumab Ozogamicin and ...

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Olaparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as temozolomide, work in ...

6. Oncología (médica) - Ensayos clínicos

   Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as obinutuzumab, may ...

7. Hematología - Ensayos clínicos

   ... enzymes needed for cell growth. International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study). Rochester, Minn. This is an ...

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Olaparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as temozolomide, work ...

9. Hematología - Ensayos clínicos

   ... enzymes needed for cell growth. Long-Term Follow-Up Of Patients Who Have Participated In Children's Oncology Group Studies. Rochester, Minn. This clinical ...

10. Hematología - Ensayos clínicos

    ... enzymes needed for cell growth. A Study to Provide Access to CTL019 Out of Specification Managed Access Program (MAP) for ALL or DLBCL Patients. Jacksonville ...